<DOC>
	<DOCNO>NCT01083290</DOCNO>
	<brief_summary>Objective investigate pharmacokinetics estimate level dose linearity spironolactone metabolites canrenone 7Î±-thiomethylspirolactone Spironolactone 25 mg , 50 mg 100 mg Tablets</brief_summary>
	<brief_title>Pharmacokinetic Study Spironolactone 25 mg , 50 mg 100 mg Tablets</brief_title>
	<detailed_description />
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Subjects normal finding determine baseline history , physical examination vital sign , haemogram , biochemistry , infectious disease screening , urinalysis , 12 lead ECG Any condition require regular concomitant medication likely need concomitant medication study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>spironolactone</keyword>
	<keyword>linearity pharmacokinetics</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>